These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1706903)
1. [Comparative study of parenteral and oral immunization against influenza in a large clinical trial. 2. Results of immunologic studies]. Tischner H; Popp M; Hien NT; Finke EJ; Nordheim W; Bräuniger S; Werchan D; Luther P; Dittmann S Z Erkr Atmungsorgane; 1990; 175(3):147-54. PubMed ID: 1706903 [TBL] [Abstract][Full Text] [Related]
2. [Comparative study of parenteral and oral immunization to influenza in a large clinical trial. 1. Results of clinico-epidemiologic studies]. Tischner H; Popp M; Herrmann H; Finke EJ; Totzke O; Nordheim W; Bräuniger S; Werchan D; Luther P; Dittmann S Z Erkr Atmungsorgane; 1990; 175(2):64-9. PubMed ID: 2264362 [TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
4. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine. Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461 [TBL] [Abstract][Full Text] [Related]
5. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382 [TBL] [Abstract][Full Text] [Related]
6. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311 [TBL] [Abstract][Full Text] [Related]
7. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization. Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505 [TBL] [Abstract][Full Text] [Related]
9. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination. Muhamed G; Greenbaum E; Zakay-Rones Z Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and immunologic effects following oral immunization against influenza in children in day care and infection susceptible young children]. Wiersbitzky S; Bruns R; Seidel E; Tischner H; Broda J; Gocht A; Dorn U; Luther P Padiatr Grenzgeb; 1990; 29(1):43-51. PubMed ID: 2342818 [TBL] [Abstract][Full Text] [Related]
11. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity. Bakke H; Samdal HH; Holst J; Oftung F; Haugen IL; Kristoffersen AC; Haugan A; Janakova L; Korsvold GE; Krogh G; Andersen EA; Djupesland P; Holand T; Rappuoli R; Haneberg B Scand J Immunol; 2006 Mar; 63(3):223-31. PubMed ID: 16499576 [TBL] [Abstract][Full Text] [Related]
12. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation. Prevost JM; Vereerstraeten-Schmerber J; Lamy F; De Koster JP Scand J Respir Dis; 1975 May; 56(1):58-69. PubMed ID: 1096297 [TBL] [Abstract][Full Text] [Related]
13. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Moldoveanu Z; Clements ML; Prince SJ; Murphy BR; Mestecky J Vaccine; 1995 Aug; 13(11):1006-12. PubMed ID: 8525683 [TBL] [Abstract][Full Text] [Related]
14. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine. Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681 [TBL] [Abstract][Full Text] [Related]
15. [Long-term effect of oral immunization against influenza with a gamma ray-inactivated vaccine in mice]. Noack K; Tischner H; Bräuniger S; Nordheim W; Pohl WD Z Erkr Atmungsorgane; 1986; 166(3):286-9. PubMed ID: 3751154 [TBL] [Abstract][Full Text] [Related]
16. Secretory immune response after nasal vaccination with live attenuated influenza viruses. Crifö S; Vella S; Filiaci F; Resta S; Rocchi G Rhinology; 1980 Jun; 18(2):87-92. PubMed ID: 7403787 [TBL] [Abstract][Full Text] [Related]
17. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645 [TBL] [Abstract][Full Text] [Related]
18. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]